Our researchers have identified a key protein that triggers the earliest stages of diabetic retinopathy.

Together Type 1 is a UK-wide youth programme funded by the Steve Morgan Foundation and run by us. We understand that living with type 1 diabetes can be hard - at times it can be frustrating, ...

If you come from a South Asian background you are at a higher risk of developing Type 2 diabetes. Diabetes is serious but the good news is that there are a number of ways you can reduce your risk of ...

Ingredients 400g tin chickpeas, drained and rinsed 300g pack cooked beetroot in natural juices/water, drained 1 clove garlic, crushed pinch cayenne pepper 1 tsp cumin freshly ground black pepper 2 tsp ...

© The British Diabetic Association operating as Diabetes UK, a charity registered in England and Wales (no. 215199) and in Scotland (no. SC039136). A company limited ...

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...

Scientists in the United States have announced early results from a pioneering trial testing a new stem cell treatment designed to replace insulin-producing beta cells in people with type 1 diabetes.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Our new analysis predicts that, without significant government action, up to 5.5m people in the UK could be living with diabetes by 2030.

Missed checks, disrupted care and health inequalities have been revealed in our new report looking at the state of diabetes care in England.

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...